Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Saved in:
| Title: | Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine. |
|---|---|
| Authors: | Podany AT; University of Nebraska Medical Center, Omaha, Nebraska, USA., Pham M; University of Nebraska Medical Center, Omaha, Nebraska, USA., Sizemore E; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Martinson N; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Samaneka W; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Mohapi L; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Badal-Faesen S; University of Witwatersrand Helen Joseph CRS, Johannesburg, South Africa., Dawson R; University of Cape Town Lung Institute, Cape Town, South Africa., Johnson JL; Case Western Reserve University, Cleveland, Ohio, USA., Mayanja H; Uganda- Case Western Reserve University Research Collaboration, Kampala, Uganda., Lalloo U; Durban International Clinical Research Site, Durban, South Africa., Whitworth WC; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Pettit A; Vanderbilt University, Nashville, Tennessee, USA., Campbell K; University of Nebraska Medical Center, Omaha, Nebraska, USA.; University of Colorado, Denver, Colorado, USA., Phillips PPJ; University of California, San Francisco Center for Tuberculosis, San Francisco, California, USA., Bryant K; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Scott N; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Vernon A; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kurbatova EV; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chaisson RE; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Dorman SE; Medical University of South Carolina, Columbia, South Carolina, USA., Nahid P; University of California, San Francisco Center for Tuberculosis, San Francisco, California, USA., Swindells S; University of Nebraska Medical Center, Omaha, Nebraska, USA., Dooley KE; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Fletcher CV; University of Nebraska Medical Center, Omaha, Nebraska, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 Sep 10; Vol. 75 (4), pp. 560-566. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
